# OnCo record nct07196644 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07196644/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07196644", "NCT07196644" ;
  schema:name "A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan"@en ;
  schema:description "A phase 2 trial of Telisotuzumab adizutecan in advanced solid tumours, run by AbbVie, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07196644/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07196644> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-12-01" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/telisotuzumab-adizutecan/> ;
  onco:companies <https://onco.cc/companies/abbvie/> .